Science Translational Medicine reports that a new drug originally developed for type 2 diabetes is being prepared for human clinical trials in hope of finding the world's first treatment to slow Parkinson's disease.
The drug was developed by Kalamazoo-based Metabolic Solutions Development Company and supported by research from Van Andel Research Institute's Center for Neurodegenerative Science.
Living here in Grand Rapids we have already heard about some of the breakthrough technology that is happening on the Medical Mile (Michigan Avenue). But again another breakthrough has put our medical community on the world wide map! The Van Andel Institute & MSU's Medical School are helping test a drug that researchers are saying may ease the symptoms and halt the advance of Parkinson's di